SANSanofi
77.61EUR-0.39%Mkt Cap: 101.30B $P/E: 24.01

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelit…

Key Statistics

Company
Market Cap101.30B $
Enterprise Value120.42B $
Revenue (TTM)53.17B $
Gross Profit36.59B $
Net Income (TTM)8.49B $
Revenue/Share44.02 USD
Last Price77.61 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees74.8K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000120578
Valuation
P/E (Trailing)24.01
P/E (Forward)8.58
PEG29.79
EV/EBITDA8.18
EV/Revenue2.26
P/S1.91
P/B1.35
EPS (TTM)3.24
EPS (Forward)9.07
52W Range
71.2532% of range91.15
52W High91.15 EUR
52W Low71.25 EUR
Profitability
Gross Margin72.07%
Oper. Margin21.03%
EBITDA Margin27.68%
Profit Margin16.72%
ROE10.95%
ROA6.16%
Growth
Revenue Growth14.60%
Earnings Growth-91.20%
Cash Flow & Leverage
Operating CF11.68B $
CapEx (TTM)3.85B $
FCF Margin12.88%
FCF Yield6.76%
Net Debt18.72B $
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.28
Current Ratio0.99
Quick Ratio0.49
Book Value/Sh57.77 EUR
Cash/Share5.300 EUR
Dividends
Fwd Div Rate4.120 EUR
Trail. Div Rate4.120 EUR
Div. Yield5.24%
5Y Avg Yield4.04%
Payout Ratio127.16%
Ex-Div DateMay 5, 2026
Pay Date
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)94.28 EUR
Upside (mean)+21.5%
Target Range78.00 EUR112.00 EUR
78.00+21.5% to mean112.00
# Analysts23
Ownership
Shares Out.1.20B
Float1.08B
Insiders10.31%
Institutions42.96%
Technical
SMA 5075.65 (+2.6%)
SMA 20079.11 (-1.9%)
Beta0.28
S&P 52W Chg18.16%
Avg Vol (30d)1.20M
Avg Vol (10d)1.65M
Technical Indicators
RSI (14)57.7
MACD0.4124
MACD Signal0.0974
MACD Hist.+0.3149
BB Upper80.00 EUR
BB Middle76.10 EUR
BB Lower72.20 EUR
BB Width10.25%
ATR (14)1.671 EUR
Vol Ratio (20d)0.58x